Trademarkia Logo

Canada

C$
DRAGON ELIXIR & LOGO DESIGN
REGISTERED

on 17 May 2023

Last Applicant/ Owned by

SAMUEL BENTATA

410-16 CARLUKE CRESNORTH YORK

ONTARIO

CA

M2L2H9

Serial Number

2104243 filed on 3rd May 2021

Registration Number

TMA1180486 registered on 17th May 2023

Registration expiry Date

17th May 2033

DRAGON ELIXIR & LOGO DESIGN

Trademark usage description

botanical supplements for general health and well-being; botanicals for the treatment of cancer; botanicals for the treatment of inflammatory bowel di Read More

Vienna Information


1 . 15 . 15

DropsGouttes

4 . 3 . 3

DragonsDragons

5 . 3 . 11

Other leavesAutres feuilles

5 . 3 . 13

Stylized leavesFeuilles stylisées

5 . 3 . 15

Two to four leavesDeux à quatre feuilles

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 11

Letters underlined, overlined, framed or barred by one or more strokesLettres soulignées, surlignées, encadrées ou barrées d'un ou de plusieurs traits

Classification Information


Class [005]
Botanical supplements for general health and well-being; botanicals for the treatment of cancer; botanicals for the treatment of inflammatory bowel disease and connective tissue diseases; cannabidiol (CBD) derived from hemp for medicinal purposes; cannabidiol [CBD] oil for medical purposes; cannabis oil for the treatment of cancer; CBD oil for medical purposes; dietary supplements for general health and well-being; hemp oil for medicinal purposes; herbal supplements for general health and well-being; herbal supplements for the treatment of arthritis; herbal supplements for the treatment of cancer; herbal supplements for the treatment of cardiovascular diseases; herbal supplements for the treatment of headaches; herbal supplements for the treatment of inflammatory diseases, namely inflammatory bowel diseases and inflammatory connective tissue diseases; herbal supplements for the treatment of the musculoskeletal system, namely, connective tissue diseases, cartilage injuries; herbal supplements for the treatment of the respiratory system; herbal supplements for use in dermatology, namely, dermatitis, eczema, psoriasis; liquid vitamin supplements; massage gels for pain relief; medicinal cannabis; medicinal cannabis for temporary relief of seizures; medicinal cannabis for the relief of nausea caused by chemotherapy; medicinal cannabis for the relief of nerve pain; medicinal cannabis for the treatment of muscle spasms caused by multiple sclerosis; medicinal marijuana; medicinal marijuana for temporary relief of seizures; medicinal marijuana for the relief of nausea caused by chemotherapy; medicinal marijuana for the relief of nerve pain; medicinal marijuana for the treatment of muscle spasms caused by multiple sclerosis; mineral nutritional supplements; mineral supplements; nutritional supplements for general health and well-being; pain relief medication; pain relief medicines; pain relief preparations; tetrahydrocannabinol [THC] oil for medical purposes; THC oil for medical purposes; topical analgesic creams; topical analgesics; topical gel for treatment of scars; vitamin and mineral dietary supplements; vitamin and mineral supplements


Classification kind code

11

Mark Details


Serial Number

2104243

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 190
on 17th May 2023
Registration Pending
Submitted for opposition 55
on 17th May 2023
Registered
Submitted for opposition 42
on 22nd Feb 2023
Advertised
Submitted for opposition 26
on 24th Jan 2023
Approved
Submitted for opposition 27
on 24th Jan 2023
Approval Notice Sent
Submitted for opposition 22
on 22nd Dec 2022
Search Recorded
Submitted for opposition 20
on 22nd Dec 2022
Examiner's First Report
Submitted for opposition 30
on 3rd May 2021
Filed
Submitted for opposition 1
on 3rd May 2021
Created
Submitted for opposition 31
on 3rd May 2021
Formalized